ArchiMed Pte. Ltd. — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Corealiscorealispharma.cominMay 2022
Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies.
Advanced ManufacturingBiotechHealthtechMedical DevicesLaval, CA
David Leroux-Petersen(Chief Executive Officer)inPatrick Gosselin(Vice-President, Pharmaceutical R&D)Yves Mouget(Vice-President, Analytics)Pascal Tougas(Chief Financial Officer)in
Co-investorsARCHIMED JapanLa Caisse
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.